We are live on ! Find out more
CI

Cowen Inc Portfolio holdings

AUM $1.39B
1-Year Est. Return 60.14%
This Fund
S&P 500
This Quarter Est. Return
+23.03%
1 Year Est. Return
+60.14%
3 Year Est. Return
+251.81%
5 Year Est. Return
+491.3%
10 Year Est. Return
AUM
$2.83B
AUM Growth
+$977M
Cap. Flow
+$786M
Cap. Flow %
27.81%
Top 10 Hldgs %
70.29%
Holding
427
New
118
Increased
44
Reduced
47
Closed
202

Sector Composition

Rank Sector Weight
1 Communication Services 26.29%
2 Technology 12.86%
3 Industrials 2.27%
4 Utilities 2.1%
5 Healthcare 1.89%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ZBH icon
326
PUT
Zimmer Biomet
ZBH
$17.7B
-5,150
Closed -$642K
ARQ icon
327
Arq
ARQ
$88.9M
-97,203
Closed -$890K
TVRD
328
CALL
Tvardi Therapeutics
TVRD
$19.5M
-208
Closed -$115K
TVRD
329
Tvardi Therapeutics
TVRD
$19.5M
-222
Closed -$123K
TVRD
330
PUT
Tvardi Therapeutics
TVRD
$19.5M
-392
Closed -$217K
SNAX
331
DELISTED
Stryve Foods, Inc. Class A Common Stock
SNAX
-10,897
Closed -$1.65M
VGR
332
DELISTED
Vector Group Ltd.
VGR
-54,028
Closed -$706K
ISUN
333
DELISTED
iSun, Inc. Common Stock
ISUN
-105,200
Closed -$1.08M
MARK
334
DELISTED
Remark Holdings, Inc.
MARK
-2,222
Closed
RAD
335
CALL
DELISTED
Rite Aid Corporation
RAD
-80,165
Closed -$4.73M
RAD
336
PUT
DELISTED
Rite Aid Corporation
RAD
-81,245
Closed -$4.79M
MGI
337
PUT
DELISTED
MoneyGram International, Inc. New
MGI
-286,800
Closed -$4.95M
CLVS
338
CALL
DELISTED
Clovis Oncology, Inc.
CLVS
-20,000
Closed -$1.87M
CLVS
339
DELISTED
Clovis Oncology, Inc.
CLVS
-2,800
Closed -$262K
CLVS
340
PUT
DELISTED
Clovis Oncology, Inc.
CLVS
-2,500
Closed -$234K
AERI
341
CALL
DELISTED
Aerie Pharmaceuticals
AERI
-10,000
Closed -$526K
GBT
342
CALL
DELISTED
Global Blood Therapeutics, Inc.
GBT
-8,800
Closed -$241K
GBT
343
PUT
DELISTED
Global Blood Therapeutics, Inc.
GBT
-8,800
Closed -$241K
CTXS
344
CALL
DELISTED
Citrix Systems Inc
CTXS
-12,600
Closed -$1M
CTXS
345
DELISTED
Citrix Systems Inc
CTXS
-10,300
Closed -$820K
TWNKW
346
DELISTED
Hostess Brands, Inc. Warrants
TWNKW
-73,701
Closed -$214K
PTLA
347
PUT
DELISTED
Portola Pharmaceuticals, Inc.
PTLA
-22,600
Closed -$1.27M
AKRX
348
CALL
DELISTED
Akorn Inc
AKRX
-200,800
Closed -$6.74M
CISN
349
DELISTED
Cision Ltd. Ordinary Share
CISN
-25,000
Closed -$257K
MDCO
350
DELISTED
Medicines Co
MDCO
-11,000
Closed -$418K

Similar funds

Cowen Inc's Q3 2017 Portfolio in Review

As of Q3 2017, Cowen Inc held 427 positions worth $2.83B, up 53% from $1.85B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Cowen Inc deployed $786M of net new capital in Q3 2017, opening 118 new positions and adding to 44 existing holdings. Its largest new stake was Kite Pharma, Inc.: 4,200,600 shares worth $755M.

By sector, the portfolio is most concentrated in Communication Services at 26% of assets, up from 4.9% a quarter earlier, followed by Technology and Industrials.

On the sell side, the largest reduction was Brocade Communications Systems, Inc. NEW, an estimated $140M trimmed.

  • Cowen Inc's largest Q3 2017 buy was Kite Pharma, Inc.: 4,200,600 shares worth $755M.
  • Cowen Inc added most to Time Warner Inc in Q3 2017, an estimated $230M increase.
  • Cowen Inc's biggest Q3 2017 reduction was Brocade Communications Systems, Inc. NEW, cutting an estimated $140M.
  • Cowen Inc fully exited Mobileye N.V. in Q3 2017, selling an estimated $210M.
  • Cowen Inc's ten largest holdings make up 70% of its $2.83B portfolio in Q3 2017.
  • Cowen Inc opened 118 new positions and closed 202 in Q3 2017.
  • Cowen Inc's portfolio value rose 53% quarter-over-quarter to $2.83B.

Based on Cowen Inc's 13F filing for Q3 2017, filed 14 Nov 2017.